Work

The Impact of Pacritinib on Myelofibrosis Symptoms in Patients with Moderate and Severe Thrombocytopenia: A Retrospective Analysis of Patients in the Persist-2 Study

Year: 2021

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2021-144505

Authors: Jeanne M. Palmer, Ruben A. Mesa, Stephen T. Oh, Raajit Rampal, Sarah A Buckley, Karisse Roman-Torres, Srdan Verstovsek, John Mascarenhas, Alessandro M. Vannucchi, Jean-Jacques Kiladjian, Claire N. Harrison, Prithviraj Bose, Adam R Craig, Aaron T. Gerds

Institutions: Mayo Clinic, Mayo Clinic Hospital, Mays Cancer Center at UT Health San Antonio, Washington University in St. Louis, Memorial Sloan Kettering Cancer Center, CTI BioPharma (United States), The University of Texas MD Anderson Cancer Center, Icahn School of Medicine at Mount Sinai, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Université Paris Cité, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Louis, Guy's and St Thomas' NHS Foundation Trust, Cleveland Clinic

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3215943156

Cites:

Cited by: 4

Related to: 10